As of 2026-07-17, Eli Lilly (LLY) has an overall Buy technical signal, while Novo Nordisk (NVO) reads Buy. Over the last six months LLY returned +14.5% versus NVO at -8.7% (so LLY has outperformed on price). These are automated technical readings for education, not financial advice.
| Metric | LLY | NVO |
|---|---|---|
| Price | $1,179.11 | $50.32 |
| Daily change | +0.85% | -2.25% |
| Overall signal | Buy | Buy |
| Confidence | 50% | 60% |
| 6-month return | +14.5% | -8.7% |
| RSI (14) | 55 | 63 |
| MACD | Sell | Buy |
| Trend | Uptrend | Neutral |
Eli Lilly full analysis · Novo Nordisk full analysis · Interactive chart →
⚠️ Not financial advice. Automated technical information for education only; indicators are not proven to beat buy-and-hold. © 2026 DailyTechnicals.